Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis

Haematologica. 2010 Feb;95(2):340-2; author reply 343-4. doi: 10.3324/haematol.2009.017764. Epub 2009 Oct 22.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / analogs & derivatives*
  • Azacitidine / therapeutic use*
  • Decitabine
  • Humans
  • Myelodysplastic Syndromes / drug therapy*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Decitabine
  • Azacitidine